If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new prescription treatment
Currently, the SURPASS-CVOT trial is evaluating the impact of dulaglutide and tirzepatide on cardiovascular events in patients with T2D (NCT04255433)
They support the repair of tendons, ligaments, muscles, and gut lining
The retatrutide peptide dosage chart shows that GI side effects nearly doubled in Phase 2 trials when participants were assigned directly to higher doses without titration
Co-administration with Intralipid for the management of intoxication
When taking semaglutide for weight loss, you should avoid eating fried or greasy foods and processed sugars